NF-κB as a target for oncogenic viruses.

Area of Science:

• Molecular Biology
• Cellular Biology
• Virology

Background:

• Nuclear factor-kappa B (NF-κB) is a crucial transcription factor regulating cell survival and proliferation.
• Its activity is tightly controlled by inhibitors of NF-κB (IκBs), with degradation leading to NF-κB nuclear translocation.
• Transient NF-κB activation is normal, but its deregulation is implicated in cancers and immunological disorders.

Purpose of the Study:

• To elucidate the molecular mechanisms by which viral oncoproteins activate the NF-κB signaling pathway.
• To understand how viruses hijack cellular processes for their own replication and pathogenesis.
• To highlight the role of NF-κB dysregulation in virus-associated diseases.

Main Methods:

• Review of existing literature on NF-κB signaling and viral oncogenesis.
• Analysis of molecular interactions between viral oncoproteins and NF-κB pathway components.
• Discussion of signaling cascades leading to persistent NF-κB activation.

Main Results:

• Several human oncogenic viruses, including HTLV-1, KSHV, and EBV, target the NF-κB pathway.
• Viral oncoproteins directly or indirectly modulate IκB kinase activity or IκB stability.
• This leads to sustained nuclear localization and activity of NF-κB, promoting viral persistence and cellular transformation.

Conclusions:

• Persistent NF-κB activation by viral oncoproteins is a key mechanism in virus-induced cancers and inflammatory diseases.
• Targeting viral oncoprotein interactions with the NF-κB pathway offers potential therapeutic strategies.
• Understanding these viral manipulation mechanisms is vital for developing antiviral therapies and cancer treatments.